General MedicationsTOPICALGeneric
UTICORT
BETAMETHASONE BENZOATE
Standard Dose
0.025%
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Discontinued
Summary
Approval overview UTICORT is listed in Drugs@FDA under application 018089 (NDA).
Marketing status: Discontinued Active ingredient BETAMETHASONE BENZOATE Form and strength OINTMENT;TOPICAL - 0.025% Sponsor PARKE DAVIS Submission history See approval history documents.
Structured Monograph
Clinical summary
Approval overview UTICORT is listed in Drugs@FDA under application 018089 (NDA). Marketing status: Discontinued Active ingredient BETAMETHASONE BENZOATE Form and strength OINTMENT;TOPICAL - 0.025% Sponsor PARKE DAVIS Submission history See approval history documents.
Monitoring
- • Marketing status: Discontinued
Interaction Notes
- No interaction notes stored yet.